MCRB Market Cap History



Below is a table of the MCRB market cap history going back to 6/26/2015:

Date MCRB Market Cap
6/26/20151.88B
8/7/20151.56B
11/6/20151.23B
3/7/20161.16B
5/9/20161.02B
8/5/2016386.64M
11/7/2016435.84M
3/10/2017376.63M
5/1/2017398.66M
7/31/2017548.14M
11/3/2017404.09M
3/2/2018402.42M
5/3/2018325.63M
7/26/2018330.44M
11/2/2018297.43M
2/28/2019251.63M
4/24/2019281.50M
7/31/2019190.86M
7/27/2018117.42M
10/29/2019242.18M
2/25/2020238.80M
7/28/2021687.89M
11/3/2021645.69M
2/24/2022762.80M
4/27/2022446.40M
8/1/2022500.01M
10/28/20221.01B
5/5/2023755.90M
8/4/2023633.33M
10/30/2023187.42M
3/1/2024185.74M

Also see: MCRB Shares Outstanding History
and MCRB YTD Return
MCRB Historical Market Cap:
-23.41% CAGR
MCRB Historical Market Cap: +-23.41% CAGR

Mouse over chart for data details
6/26/2015 ...3/1/2024
Seres Therapeutics is a microbiome therapeutics platform company developing live biotherapeutic drugs. SER-109, Co.'s lead clinical candidate is an oral, purified bacterial spore-based microbiome therapeutic candidate consisting of a consortium of purified Firmicutes spores. Using Co.'s microbiome therapeutics platform, Co. is also developing SER-287 and SER-301 to treat ulcerative colitis. Co. evaluates microbiome pharmacokinetic and pharmacodynamic data from across its clinical and pre-clinical portfolios using its reverse translation microbiome therapeutics capabilities to conduct research on various indications, including inflammatory and immune diseases, cancer, and metabolic diseases. We show 31 historical shares outstanding datapoints in our MCRB shares outstanding history coverage, used to compute MCRB market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing MCRB market cap history over the course of time is important for investors interested in comparing MCRB's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of MCRB versus a peer is one thing; comparing MCRB market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like MCRB can fluctuate over the course of history. With this page we aim to empower investors researching MCRB by allowing them to research the MCRB market cap history.
Quotes delayed 20 minutes

Email EnvelopeFree MCRB Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Seres Therapeutics (MCRB) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

MD Market Cap History
MDCO Market Cap History
MDGL Market Cap History
MDT Market Cap History
MDXG Market Cap History
ME Market Cap History
MEDP Market Cap History
MEIP Market Cap History
MGEN Market Cap History
MGLN Market Cap History
More Healthcare companies »

 

MCRB Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2024, All Rights Reserved

Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 9.5%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 9.5%.